Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. It offers minimally-invasive endovascular repair (EVAR) products, including the AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system. The VELA Proximal Endograft is designed for the treatment of proximal aortic neck anatomies with AFX, and the company also provides the Ovation abdominal stent graft system.
The company also provides an endovascular sealing (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm and provides blood flow to the legs through two blood lumens. In addition, it offers proximal aortic extensions and limb extensions, which attach to the main body of its EVAR device, allowing physicians to customize it to fit the patient's anatomy. Accessories to facilitate the optimal delivery of its EVAR products include compatible guidewires, inflation devices, and snares.
The company offers its EVAR products under the Powerlink System, IntuiTrak, AFX, and VELA Proximal Endograft brand names, while EVAS products are offered under the Nellix EVAS system brand name. It sells its products through a direct sales force, a network of agents, and independent distributors or agents.
The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.
